10-K: Adtalem Global Education Reports Fiscal Year 2024 Results, Revenue Up 9.2%

Adtalem Global Education Inc. reports a 9.2% increase in revenue for fiscal year 2024, driven by growth across all segments.

Summary

• Adtalem Global Education Inc. reported a 9.2% increase in revenue, reaching $1,584.7 million for fiscal year 2024.
• Net income saw a significant rise of 46.5%, totaling $136.8 million, compared to the previous year.
• Diluted earnings per share increased by 65.4% to $3.39.
• Adjusted net income increased by 5.0% to $201.8 million.
• Diluted adjusted earnings per share rose by 19.0% to $5.01.
• Chamberlain University's student enrollment increased by 10.4% in the May 2024 session.
• Walden University's student enrollment increased by 11.3% as of June 30, 2024.
• The medical and veterinary schools experienced a 2.9% decrease in student enrollment in the May 2024 semester.
• Adtalem repurchased 5,446,113 shares of its common stock at an average cost of $47.96 per share during fiscal year 2024.
• A $50.0 million prepayment was made on the Term Loan B debt.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with strong financial results and enrollment growth in key segments. However, there are some concerns regarding regulatory issues and enrollment declines in the medical and veterinary schools.

Positives

• Revenue growth was seen across all of Adtalem's segments.
• Net income and diluted earnings per share showed substantial increases.
• Both Chamberlain and Walden Universities experienced significant enrollment growth.
• The company successfully reduced its debt through a prepayment on the Term Loan B.
• Adtalem's share repurchase program continues, indicating confidence in the company's value.

Negatives

• The medical and veterinary schools experienced a decrease in student enrollment.
• The company's composite score declined to 0.2, requiring a letter of credit and provisional certification.

Risks

• Adtalem is subject to regulatory audits, investigations, and lawsuits.
• Changes in government funding and regulations could adversely affect the company.
• The company faces competition in the postsecondary education market.
• Cybersecurity risks and data breaches could impact operations and reputation.
• Failure to comply with regulations could result in loss of access to federal and state student financial aid.
• A bankruptcy filing by Adtalem or any of its Title IV institutions would lead to an immediate loss of eligibility to participate in Title IV programs.
• Excessive student loan defaults could result in the loss of eligibility to participate in Title IV programs.
• The company's ability to comply with some ED regulations is affected by economic forces affecting students and graduates that are not entirely within its control.

Future Outlook

Management anticipates fiscal year 2025 capital spending to be in the $55 to $75 million range. Adtalem is reviewing the new Financial Value Transparency (FVT) and Gainful Employment (GE) rules to determine their impact.

Management Comments

• Adtalem remains focused on expanding access to aspiring students through a seamless student experience, leveraging innovative learning technologies, diversifying into new program areas, and integrating our five institutions.
• Adtalem aims to create value for society and its stakeholders by offering responsive educational programs that are supported by exceptional services to its students and delivered with integrity and accountability.
• Management believes the imbalance between supply and demand for medical doctors and veterinarians will continue to spur demand for medical and veterinary education.

Industry Context

The document highlights the competitive nature of the online higher education market and the increasing number of traditional institutions offering online programs. It also notes the growing demand for healthcare professionals, which supports Adtalem's focus on healthcare education.

Comparison to Industry Standards

• Chamberlain had the largest pre-licensure program in the U.S. based on total enrollments in Fall 2023, according to data from the American Association of Colleges of Nursing (AACN).
• Chamberlain had the largest DNP, MSN, and FNP programs in the U.S. based on total enrollments in Fall 2023, according to AACN data.
• Walden has ranked #1 among 380 accredited institutions for awarding research doctorates to African American students.
• Walden has ranked #1 in awarding graduate degrees in multiple disciplines to African American students.
• Walden has ranked #3 for awarding research doctoral degrees in psychology, public health, and social service professions to Hispanic students.
• The default rate for all Title IV institutions nationally was 0.0% for the fiscal year 2020 cohort, 2.3% for the fiscal year 2019 cohort, and 7.3% for the fiscal year 2018 cohort, according to ED.

Management Changes

Corporate Governance

Legal Proceedings

• Walden is involved in a class action lawsuit alleging violations of Title VI of the Civil Rights Act of 1964, the Equal Credit Opportunity Act, and other state laws.
• Walden is involved in a class action lawsuit alleging violations of the Telephone Consumer Protection Act.
• Adtalem is subject to ongoing litigation and settlements related to the DeVry University and Carrington College divestitures.
• Adtalem has received notices from ED regarding borrower defense to repayment applications filed by students at Chamberlain, RUSM, RUSVM, and Walden.

Stakeholder Impact

• Shareholders benefit from increased revenue, net income, and earnings per share.
• Students at Chamberlain and Walden benefit from increased program offerings and enrollment capacity.
• Employees benefit from competitive compensation and benefits packages.
• Customers (students) may be impacted by changes in tuition rates and financial aid programs.
• Creditors are impacted by the company's debt management and financial performance.

Next Steps

• Adtalem will continue to focus on expanding access to students, leveraging technology, and diversifying program areas.
• The company will continue to monitor and respond to changes in regulations and the competitive landscape.
• Management anticipates fiscal year 2025 capital spending to be in the $55 to $75 million range.

Key Dates

Keywords

education, healthcare, nursing, medical, veterinary, enrollment, revenue, financial aid, accreditation, regulation